These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 11062274)

  • 21. Symptomatic Intracerebral Hemorrhage after Intravenous Thrombolysis: Predictive Factors and Validation of Prediction Models.
    Nisar T; Hanumanthu R; Khandelwal P
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104360. PubMed ID: 31501036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multicenter Study of Intravenous Recombinant Tissue Plasminogen Activator Infusion around Hiroshima, Japan: The Hiroshima Acute Stroke Retrospective and Prospective Registry Study.
    Aoki S; Hosomi N; Sueda Y; Kono T; Takamatsu K; Ohyama H; Torii T; Kitamura T; Nomura E; Noda K; Ohtsuki T; Matsumoto M;
    J Stroke Cerebrovasc Dis; 2015 Dec; 24(12):2747-53. PubMed ID: 26360972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety, effectiveness, and practicality of endovascular therapy within the first 3 hours of acute ischemic stroke onset.
    Mathews MS; Sharma J; Snyder KV; Natarajan SK; Siddiqui AH; Hopkins LN; Levy EI
    Neurosurgery; 2009 Nov; 65(5):860-5; discussion 865. PubMed ID: 19834397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rescue localized intra-arterial thrombolysis for hyperacute MCA ischemic stroke patients after early non-responsive intravenous tissue plasminogen activator therapy.
    Kim DJ; Kim DI; Kim SH; Lee KY; Heo JH; Han SW
    Neuroradiology; 2005 Aug; 47(8):616-21. PubMed ID: 15983773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defining mild stroke: outcomes analysis of treated and untreated mild stroke patients.
    Spokoyny I; Raman R; Ernstrom K; Khatri P; Meyer DM; Hemmen TM; Meyer BC
    J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1276-81. PubMed ID: 25906938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Temporal Trends in Intravenous Thrombolysis in Acute Ischemic Stroke: Experience from a Tertiary Care Center in India.
    Khurana D; Das B; Kumar A; Kumar S A; Khandelwal N; Lal V; Prabhakar S
    J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):1266-1273. PubMed ID: 28237123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI.
    Schellinger PD; Jansen O; Fiebach JB; Heiland S; Steiner T; Schwab S; Pohlers O; Ryssel H; Sartor K; Hacke W
    Stroke; 2000 Jun; 31(6):1318-28. PubMed ID: 10835451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute stroke with hyperdense middle cerebral artery sign benefits from IV rtPA.
    Tartaglia MC; Di Legge S; Saposnik G; Jain V; Chan R; Bussière M; Hachinski V; Frank C; Hesser K; Pelz D
    Can J Neurol Sci; 2008 Nov; 35(5):583-7. PubMed ID: 19235441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bridging intravenous-intra-arterial rescue strategy increases recanalization and the likelihood of a good outcome in nonresponder intravenous tissue plasminogen activator-treated patients: a case-control study.
    Rubiera M; Ribo M; Pagola J; Coscojuela P; Rodriguez-Luna D; Maisterra O; Ibarra B; Piñeiro S; Meler P; Romero FJ; Alvarez-Sabin J; Molina CA
    Stroke; 2011 Apr; 42(4):993-7. PubMed ID: 21372307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of a modified intravenous recombinant tissue plasminogen activator regimen in Chinese patients with acute ischemic stroke.
    Pan SM; Liu JF; Liu M; Shen S; Li HJ; Dai LH; Chen XJ
    J Stroke Cerebrovasc Dis; 2013 Jul; 22(5):690-3. PubMed ID: 23111010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systematic review of outcome after ischemic stroke due to anterior circulation occlusion treated with intravenous, intra-arterial, or combined intravenous+intra-arterial thrombolysis.
    Mullen MT; Pisapia JM; Tilwa S; Messé SR; Stein SC
    Stroke; 2012 Sep; 43(9):2350-5. PubMed ID: 22811451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneous treatment with intravenous recombinant tissue plasminogen activator and endovascular therapy for acute ischemic stroke within 3 hours of onset.
    Sugiura S; Iwaisako K; Toyota S; Takimoto H
    AJNR Am J Neuroradiol; 2008 Jun; 29(6):1061-6. PubMed ID: 18372418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study.
    Albers GW; Bates VE; Clark WM; Bell R; Verro P; Hamilton SA
    JAMA; 2000 Mar; 283(9):1145-50. PubMed ID: 10703776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pretreatment diffusion-weighted imaging lesion volume predicts favorable outcome after intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke.
    Kruetzelmann A; Köhrmann M; Sobesky J; Cheng B; Rosenkranz M; Röther J; Schellinger PD; Ringleb P; Gerloff C; Fiehler J; Thomalla G
    Stroke; 2011 May; 42(5):1251-4. PubMed ID: 21415399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decrease in blood pressure after intravenous administration of urapidil during recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke.
    Bugnicourt JM; Duru C; Picard C; Godefroy O
    Clin Ther; 2008 Sep; 30(9):1675-80. PubMed ID: 18840373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intraarterial thrombolytic therapy within 3 hours of the onset of stroke.
    Bourekas EC; Slivka AP; Shah R; Sunshine J; Suarez JI
    Neurosurgery; 2004 Jan; 54(1):39-44; discussion 44-6. PubMed ID: 14683539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Stroke Registry Data on the Use of Intravenous Recombinant Tissue Plasminogen Activator in Stroke of Unknown Time of Onset.
    Balogun IO; Brown A; Bertoni M; Webb T; Hargroves D; Pullicino P
    J Stroke Cerebrovasc Dis; 2016 Aug; 25(8):1843-50. PubMed ID: 27132489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is intra-arterial thrombolysis safe after full-dose intravenous recombinant tissue plasminogen activator for acute ischemic stroke?
    Shaltoni HM; Albright KC; Gonzales NR; Weir RU; Khaja AM; Sugg RM; Campbell MS; Cacayorin ED; Grotta JC; Noser EA
    Stroke; 2007 Jan; 38(1):80-4. PubMed ID: 17122433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does large vessel occlusion affect clinical outcome in stroke with mild neurologic deficits after intravenous thrombolysis?
    Zhu W; Churilov L; Campbell BCV; Lin M; Liu X; Davis SM; Yan B
    J Stroke Cerebrovasc Dis; 2014; 23(10):2888-2893. PubMed ID: 25440367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombolysis with alteplase for acute ischemic stroke patients with atrial fibrillation.
    Zhang JB; Ding ZY; Yang Y; Sun W; Hai F; Sui XN; Li XY; Wang HZ; Wang XT; Zheng JL
    Neurol Res; 2010 May; 32(4):353-8. PubMed ID: 20483000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.